These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Alemtuzumab.
    Author: Weaver TA, Kirk AD.
    Journal: Transplantation; 2007 Dec 27; 84(12):1545-7. PubMed ID: 18165760.
    Abstract:
    Alemtuzumab is a humanized CD52-specific monoclonal antibody that is increasingly used off-label as an induction agent in solid organ transplantation, particularly in the setting of maintenance immunosuppression minimization protocols. In this review, we briefly discuss this agent's mechanisms of action and summarize evidence supporting its use in this clinical setting.
    [Abstract] [Full Text] [Related] [New Search]